These Two Stocks in Motion: Workhorse Group, Inc. (NASDAQ:WKHS) & Soleno Therapeutics, Inc. (NASDAQ:SLNO)

18

Workhorse Group, Inc. (NASDAQ:WKHS)

Workhorse Group Inc. is engaged in designing, developing, manufacturing and selling medium-duty trucks. The Company’s products include trucks comprising powertrain and chassis. Powertrain includes E-GEN and AMP E-100. Chassis include W88, W22, W42 and W62. Workhorse Group Inc., formerly known as AMP Holding Inc., is based in Loveland, United States.

Workhorse Group, Inc. (NASDAQ:WKHS)’s Financial Overview

Workhorse Group, Inc. (NASDAQ) surged 9.87% yesterday to close its trading session at $0.78. The company has 1 year Price Target of $3.25. Workhorse Group, Inc. has 52-Week high of $3.45 and 52-Week Low of $0.37. The stock touched its 52-Week High on 3.45 and 52-Week Low on 0.37. The stock traded with the volume of 195724 shares yesterday. The firm shows the market capitalization of $40 Million.

Workhorse Group, Inc. (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-0.15/share against the analyst consensus estimate of $-0.16/share. The difference between the actual and expected EPS is $0.01 a share with a surprise factor of 6.3%.

The firm is trading with SMA20 of 31.27 Percent, SMA50 of 13.68 Percent and SMA200 of -49.16 percent. Workhorse Group, Inc. has P/S value of 6.35 while its P/B value stands at 19.5. Similarly, the company has Return on Assets of -228 percent, Return on Equity of 0 percent and Return on Investment of -398.4 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 2 analysts offering 12-month price forecasts for Workhorse Group Inc have a median target of 3.25, with a high estimate of 4.00 and a low estimate of 2.50. The median estimate represents a +316.61% increase from the last price of 0.78.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

Soleno Therapeutics, Inc. (NASDAQ:SLNO)

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada.

Soleno Therapeutics, Inc. (NASDAQ:SLNO)’s Financial Outlook

The 2 analysts offering 12-month price forecasts for Soleno Therapeutics Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +398.28% increase from the last price of 1.81.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, Soleno Therapeutics, Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock declined -0.76% and closed its last trading session at $1.81. The company has the market capitalization of $39 Million. The stock has 52-week high of $3.6 and 52-Week low of $1.45. The firm touched its 52-Week high on 3.60 and 52-Week low on 1.45. The company has volume of 18546 shares. The company has a total of 21.59 Million shares outstanding.

Soleno Therapeutics, Inc. (NASDAQ) in the last quarter reported its actual EPS of $-0.13/share where the analyst estimated EPS was $-0.22/share. The difference between the actual and Estimated EPS is $0.09. This shows a surprise factor of 40.9 percent.

The company has YTD performance of 5.63 percent. Beta for Soleno Therapeutics, Inc. stands at 3.65 while its ATR (average true range) is 0.19. The company has Weekly Volatility of 5.67%% and Monthly Volatility of 11.34%%.

Soleno Therapeutics, Inc. has distance from 20-day Simple Moving Average (SMA20) of 6.98%, Distance from 50-Day Simple Moving Average of -3.97 percent and Distance from 200-Day Simple Moving Average of -13.65%.

The Company currently has ROA (Return on Assets) of -49.7 percent, Return on Equity (ROE) of -87.2 Percent and Return on Investment (ROI) of 0% with Gross margin of 0 percent and Operating & Profit margin of 0% and 0% respectively.

SHARE